Venlafaxine Hydrochloride
Product Images NDC 50090-5145

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01)

A chart showing pharmacokinetic fold change and 90% confidence interval recommendations for venlafaxine hydrochloride when interacting with various drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value, and the chart provides guidance on dose adjustments or cautions for each interacting drug.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02)

A pharmacokinetic fold change chart showing the effect of various interacting drugs on analyte levels (Cmax and AUC). Drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. Recommendations for dose adjustment or caution are provided beside each drug. The x-axis represents fold change relative to the reference value, ranging from 0 to 3.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03)

A scatter plot chart showing fold change and 90% confidence intervals for venlafaxine pharmacokinetics (Cmax and AUC) across different special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. Recommendations for dosing adjustments are listed on the right side of the chart.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04)

Chemical structure of venlafaxine hydrochloride showing its molecular components including a methoxy phenyl group, a cyclohexane ring, a hydroxyl group, and a dimethylaminoethyl side chain, along with the hydrochloride (HCl) component, as labeled in the image.*

FDA Label Image

Label Image (Lbl500905145)

Packaging label for venlafaxine hydrochloride 75 mg released capsules by A-S Medication Solutions. The label displays the NDC 50090-5145-0, product number 6226-0, and specifies a 30-count package. Storage instructions indicate to store at 20 to 70 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.